{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:13:20Z","timestamp":1778271200826,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00384-017-2794-8","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T03:50:14Z","timestamp":1489463414000},"page":"661-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Long-standing Crohn\u2019s disease and its implication on anal squamous cell cancer management"],"prefix":"10.1007","volume":"32","author":[{"given":"Amy L","family":"Lightner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara B.","family":"Moncrief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Smyrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Dozois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie L.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"issue":"2","key":"2794_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.12816\/0006000","volume":"6","author":"SA Salati","year":"2012","unstructured":"Salati SA, Al KA (2012) Anal cancer: a review. Int J Health Sci (Qassim) 6(2):206\u2013230","journal-title":"Int J Health Sci (Qassim)"},{"issue":"10","key":"2794_CR2","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","volume":"24","author":"MS Shiels","year":"2015","unstructured":"Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS (2015) Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior. Cancer Epidemiol Biomark Prev 24(10):1548\u20131556","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"2794_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1071\/SH12070","volume":"9","author":"AE Grulich","year":"2012","unstructured":"Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ (2012) The epidemiology of anal cancer. Sex Health 9(6):504\u2013508","journal-title":"Sex Health"},{"issue":"10","key":"2794_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/ijc.24215","volume":"124","author":"BE Hoots","year":"2009","unstructured":"Hoots BE, Palefsky JM, Pimenta JM, Smith JS (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 124(10):2375\u20132383","journal-title":"Int J Cancer"},{"issue":"5","key":"2794_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","volume":"13","author":"DA Machalek","year":"2012","unstructured":"Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM et al (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13(5):487\u2013500","journal-title":"Lancet Oncol"},{"issue":"3","key":"2794_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1081\/CNV-120018238","volume":"21","author":"JE Gervasoni Jr","year":"2003","unstructured":"Gervasoni JE Jr, Wanebo HJ (2003 Jun) Cancers of the anal canal and anal margin. Cancer Investig 21(3):452\u2013464","journal-title":"Cancer Investig"},{"issue":"3","key":"2794_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ijc.25080","volume":"127","author":"KG Sunesen","year":"2010","unstructured":"Sunesen KG, Norgaard M, Thorlacius-Ussing O, Laurberg S (2010) Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005. Int J Cancer 127(3):675\u2013684","journal-title":"Int J Cancer"},{"key":"2794_CR8","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/ctg.2016.8","volume":"7","author":"J Ruel","year":"2016","unstructured":"Ruel J, Ko HM, Roda G, Patil N, Zhang D, Jharap B et al (2016) Anal neoplasia in inflammatory bowel disease is associated with HPV and perianal disease. Clin Transl Gastroenterol 7:e148","journal-title":"Clin Transl Gastroenterol"},{"key":"2794_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4137\/CMO.S13241","volume":"8","author":"B Gami","year":"2014","unstructured":"Gami B, Kubba F, Ziprin P (2014) Human papilloma virus and squamous cell carcinoma of the anus. Clin Med Insights Oncol 8:113\u2013119","journal-title":"Clin Med Insights Oncol"},{"issue":"4 Suppl 1","key":"2794_CR10","doi-asserted-by":"publisher","first-page":"S-410","DOI":"10.1016\/S0016-5085(13)61510-3","volume":"144","author":"R Cranston","year":"2013","unstructured":"Cranston R, Baker J, Mowrey C, Janocko L, Burneisen S, Fultz J et al (2013) Inflammatory bowel disease patients have a high prevalence of anal human papillomavirus and anal dysplasia [abstract]. Gastroenterology 144(4 Suppl 1):S-410","journal-title":"Gastroenterology"},{"issue":"11","key":"2794_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.cgh.2015.05.031","volume":"13","author":"SB Shah","year":"2015","unstructured":"Shah SB, Pickham D, Araya H, Kamal A, Pineda CE, Ghole S et al (2015) Prevalence of anal dysplasia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 13(11):1955\u20131961 e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"17","key":"2794_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H et al (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365(17):1576\u20131585","journal-title":"N Engl J Med"},{"key":"2794_CR13","unstructured":"National Comprehensive Cancer Network (NCCN). [cited 2016 Nov 8]; Available from: \nhttps:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL\n\n=\nhttps:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/anal.pdf\n\n."},{"key":"2794_CR14","doi-asserted-by":"publisher","unstructured":"Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon rectum 17(3):354\u2013356","DOI":"10.1007\/BF02586980"},{"issue":"11","key":"2794_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM200003163421107","volume":"342","author":"DP Ryan","year":"2000","unstructured":"Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342(11):792\u2013800","journal-title":"N Engl J Med"},{"issue":"8","key":"2794_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/BF02586688","volume":"20","author":"TR Buroker","year":"1977","unstructured":"Buroker TR, Nigro N, Bradley G, Pelok L, Chomchai C, Considine B et al (1977) Combined therapy for cancer of the anal canal: a follow-up report. Dis Colon rectum 20(8):677\u2013678","journal-title":"Dis Colon rectum"},{"issue":"2","key":"2794_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02604287","volume":"24","author":"ND Nigro","year":"1981","unstructured":"Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B (1981) Combined therapy for cancer of the anal canal. Dis Colon rectum 24(2):73\u201375","journal-title":"Dis Colon rectum"},{"issue":"5","key":"2794_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/0360-3016(91)90265-6","volume":"21","author":"BJ Cummings","year":"1991","unstructured":"Cummings BJ, Keane TJ, O\u2019Sullivan B, Wong CS, Catton CN (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21(5):1115\u20131125","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2B","key":"2794_CR19","first-page":"1335","volume":"28","author":"N Raffetto","year":"2008","unstructured":"Raffetto N, Monaco A, Banelli E (2008) Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma. Anticancer Res 28(2B):1335\u20131339","journal-title":"Anticancer Res"},{"issue":"9034","key":"2794_CR20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR Anal Cancer Trial Working Party","year":"1996","unstructured":"UKCCCR Anal Cancer Trial Working Party (1996) UK co-ordinating committee on cancer research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348(9034):1049\u20131054","journal-title":"Lancet"},{"issue":"9","key":"2794_CR21","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14(9):2527\u20132539","journal-title":"J Clin Oncol"},{"issue":"5","key":"2794_CR22","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15(5):2040\u20132049","journal-title":"J Clin Oncol"},{"issue":"2","key":"2794_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10350-007-9125-z","volume":"51","author":"R Roohipour","year":"2008","unstructured":"Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG et al (2008) Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon rectum 51(2):147\u2013153","journal-title":"Dis Colon rectum"},{"issue":"35","key":"2794_CR24","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd et al (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol 30(35):4344\u20134351","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-017-2794-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-017-2794-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-017-2794-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T05:53:38Z","timestamp":1492581218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-017-2794-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1007\/s00384-017-2794-8","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}